维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Triplitt"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Effects of exenatide plus rosiglitazone on (beta)-cell function and Insulin sensitivity in subjects with type 2 diabetes on metformin显示文摘	eFronzo RA Triplitt C Qu Y	2010	Diabetes Care2010，33，5：	1
2	Effect of rosiglitazone on glucose and non- esterified fatty acid metabolism in Type II diabetic patients显示文摘	Miyazaki Y Glass L Triplitt C	2001	Diabetologia2001，44，：	1
3	Exenatide: from the Gila monster to the pharmacy显示文摘	Triplitt C Chiquette E	2006	J Am Pharm Assoc2006，46，1：	1
4	Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus显示文摘	Miyazaki KM Glass L Triplitt C	2002	Am J Physiol Endocrinol Metab2002，283，6：	1
5	Dose-Response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects 显示文摘	Wajcberg E Miyazaki Y Triplitt C	2004	Diabetes Care2004，27，12：	1
6	Addition of pioglitazone and ramipril to inlensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms 显示文摘	Fernandez M Triplitt C Wajcberg E	2008	Diabetes Care2008，31，1：	1
7	Rosiglitazone decreases albuminuria in type 2 diabetic patients 显示文摘	Miyazaki Y Cersosimo E Triplitt C	2007	Kidney Int2007，72，11：	1
8	New technologies and therapies in the management of diabetes显示文摘	Triplitt CL	2007	Am J Manag Care2007，13，2：	1
9	Abdominal fat distribution and peripheral and inshlin resistance in type 2 diabets mellitus显示文摘	Miyazaki Y Glass L Triplitt C Wajcberg E Mandarino LJ De-Fronzo RA	2002	Pediatr Endoerinol Metab2002，283，6：	1
10	Rosiglitazone decreasesalbuminuria in type 2 diabetic patients显示文摘	Miyazaki Y Cersosimo E Triplitt C	2007	Kidney Int2007，72，11：	1
11	Effects of exenatide plus rosiglitazone on 13-Cell function and insulin sensitivity in subjects with type 2 diabetes on mefformin 显示文摘	DeFronzo RA Triplitt C Qu Y	2010	Diabetes Care2010，33，5：	1
12	Rosiglitazone decreases albuminuria in type 2 diabetic patients显示文摘	Miyazaki Y Cersosimo E Triplitt C	2007	Kidney Int2007，72，：	1
13	Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus 显示文摘	Miyazaki Y Glass L Triplitt C	2002	Am J Physiol Endocrinol Metab2002，283，6：	1
14	Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improvesvascular dysfunction by different mechanisms显示文摘	Fernandez M Triplitt C Wajcberg E	2008	Diabetes Care2008，31，1：	1
15	Exenatide:from the Gila monster to the pharmacy显示文摘	Triplitt C Chiquette E		0，，：	1
16	Rosiglitazone decreases albuminuria in type 2 diabetic patients 显示文摘	Miyazaki Y Cersosimo E Triplitt C	2007	Kidney Int2007，72，11：	1
17	Metabolic effects of muraglitazar in type 2 diabetic subjects显示文摘	Fernandez M Gastaldelli A Triplitt C	2011	Diabetes Obes Metab2011，13，89：	1
18	Metabolic effects of muraglitazar in type 2 diabetic subjects 显示文摘	Fernandez M Gastaldelli A Triplitt C	2011	Diabetes Obes Metab2011，13，10：	1
19	Rosiglitazone decreases al- buminuria in type 2 diabetic patients 显示文摘	Miyazaki Y Cersosimo E Triplitt C	2007	Kidney Int2007，72，11：	1
20	Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin 显示文摘	DEFRONZO RA TRIPLITT C QU Y	2010	Diabetes Care2010，33，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示